A new targeted PET/CT tracer can detect treatment response in rheumatoid arthritis patients in as little as four weeks, and potentially even at the start of treatment, according to new research ...

A macrophage-targeted PET/CT tracer predicts anti-TNF response in rheumatoid arthritis at baseline and four weeks, enabling ...

A widely used treatment for rheumatoid arthritis may offer an unexpected cardiovascular benefit. Methotrexate has been a staple treatment for rheumatoid arthritis for decades, valued for its ability ...

More than 80% of patients with newly diagnosed rheumatoid arthritis, who were using bridging therapy, successfully tapered ...

London, UK – 3 March, 2026 – Quell Therapeutics Ltd (“Quell”), today announced that it has initiated a Phase 1/2 basket clinical study evaluating ...

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Obesity represents a significant barrier to treatment effectiveness, and by extension treatment ...

—Investigators conducted a secondary analysis of the TARGET trial to determine differences in cardiovascular risk between rheumatoid arthritis patients treated with triple therapy or tumor necrosis ...

Although rheumatoid arthritis is an autoimmune disease with no cure, a tailored, multidisciplinary treatment approach at Cedars-Sinai's Inflammatory Arthritis Clinical Center helps patients get back ...

Add Yahoo as a preferred source to see more of our stories on Google. Tammi L Shlotzhauer is a distinguished American medic and the author of ‘Living with Rheumatoid Arthritis’ - Barbara Patskin Tammi ...

A new targeted PET/CT tracer can detect treatment response in rheumatoid arthritis patients in as little as four weeks, and ...